Results 81 to 90 of about 20,705 (157)

Beclomethasone Dipropionate, Glycopyrronium (as Bromide), and Formoterol Fumarate Dihydrate (Trimbow)

Reimbursement reviews are comprehensive assessments of the clinical effectiveness and cost-effectiveness, as well as patient and clinician perspectives, of a drug or drug class.
CDA-AMC
core   +1 more source

A Review on Development and Validation of Analytical Method for Simultaneous Estimation of Formoterol Fumarate Dehydrate and Fluticasone Propionate from Bulk and Dry Powder Inhaler Formulation

, 2019
To compare the effectiveness of formoterol fumarate dihydrate and fluticasone propionate two combination inhaled corticosteroid/long acting beta–agonist product approved for treatment of chronic obstructive pulmonary disease (COPD) in the US with respect
Magar D, Sagar, Satpute Soniya S, Sagar Magar D2, Rahul K, Godge, Satpute, Soniya S., Godge Rahul K   +5 more
core   +1 more source

Perspective on the Budgetary Impact of FP/FORM pMDI on Treatment and Management of Exacerbation in Moderate-to-Severe Asthma Patients in Singapore

ClinicoEconomics and Outcomes Research, 2020
Sebastien Boisseau,1 Murtaza Qasuri,1 Weng Tong Ho,1 Wrik Ghosh,2 Yacine Hadjiat1 1Mundipharma Singapore Holding Pte Limited, Singapore; 2Costello Medical Singapore Pte Ltd, SingaporeCorrespondence: Yacine HadjiatMundipharma Singapore Holding Pte Limited,
Boisseau S, Qasuri M, Ho WT, Ghosh W, Hadjiat Y   +4 more
doaj  

A phase IIb randomized, chronic-dosing, incomplete block, cross-over study of glycopyrronium, delivered via metered dose inhaler, compared with a placebo and an active control in patients with moderate-to-severe COPD

Respiratory Research, 2018
Background Long-acting muscarinic antagonist (LAMA) and long-acting β2-agonist (LABA) bronchodilators are key to the pharmacologic treatment of chronic obstructive pulmonary disease (COPD).
Edward M. Kerwin, Selwyn Spangenthal, Christine Kollar, Earl St Rose, Colin Reisner   +4 more
doaj   +1 more source

Simultaneous spectrophotometric determination of formoterol fumarate and budesonide in their combined dosage form

, 2006
81-83A new UV spectrophotometric method for the simultaneous determination of formoterol fumarate and budesonide in their combined dosage form has been developed.
Prasad, A V S S
core  

Bioequivalence of inhaled formoterol fumarate assessed from pharmacodynamic, safety and urinary pharmacokinetic data.

, 2000
This paper deals with a crossover trial on healthy volunteers performed to obtain combined pharmacodynamic, safety and pharmacokinetic data in order to assess the bioequivalence of formoterol fumarate (CAS 43229-80-7) delivered by mono-dose dry powder ...
PEZZUTO D, CRIVELLI F, MONTI NC, CORSICO, ANGELO GUIDO, MAZZUCCHELLI P, MARZO A, DAL BO L, TETTAMANTI RA, MEOLI A   +8 more
core   +1 more source

Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events (Review) [PDF]

, 2009
Background Epidemiological evidence has suggested a link between beta2-agonists and increases in asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta2-agonists are ...
Christopher J Cates, Jaeschke, R, Lasserson, TJ, Roman Jaeschke, Toby J Lasserson, Cates, CJ   +5 more
core   +1 more source

Long-Term Safety and Efficacy of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD

International Journal of COPD, 2019
Masakazu Ichinose,1 Yasushi Fukushima,2 Yoshikazu Inoue,3 Osamu Hataji,4 Gary T Ferguson,5 Klaus F Rabe,6 Nobuya Hayashi,7 Hiroshi Okada,7 Mami Takikawa,7 Eric Bourne,8 Shaila Ballal,9 Kiernan DeAngelis,10 Magnus Aurivillius,11 Colin Reisner,9 Paul ...
Ichinose M, Fukushima Y, Inoue Y, Hataji O, Ferguson GT, Rabe KF, Hayashi N, Okada H, Takikawa M, Bourne E, Ballal S, DeAngelis K, Aurivillius M, Reisner C, Dorinsky P   +14 more
doaj  

Development and Validation of Analytical Method for Simultaneous Estimation of Formoterol Fumarate Dihydrate and Fluticasone Propionate from Bulk and Dry Powder Inhaler Formulation

, 2019
A method was developed and validated for analysis of Formoterol Fumarate and Fluticasone Propionate in dry powder inhaler formulations. Separation was achieved on a HiQ Sil C18HS, 250×4.6 mm, 5 µm column using a mobile phase consisting of Acetonitrile: 0.
Sagar, Magar M, Satpute, Soniya S, Godge, Rahul K   +2 more
core   +1 more source

Acute formoterol administration has no ergogenic effect in nonasthmatic athletes [PDF]

, 2002
Purpose: To determine the effect of formoterol (formoterol fumarate dihydrate) on the aerobic and anaerobic capacities of highly trained athletes.\ud \ud Methods: 10 male athletes (age = 26.2 +/- 0.9, O2max = 65.6 +/- 2.4 mL[middle dot]kg-1[middle dot ...
McKenzie, Donald C., Stewart, Ian B., Labreche, Jane M.   +2 more
core